Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3353-3357

  Hidaka, Shigekazu ^a   Yasutake, Toru ^a   Kondo, Masamichi ^a   Takeshita, Hiroak ^a   Yano, Hiroshi ^a   Haseba, Masatoshi ^a   Tsuji, Takashi ^a   Sawai, Terumitsu ^a   Nakagoe, Tohru ^a   Tagawa, Yutaka ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Comparative genomic hybridization; Gastric cancer; Intestinal type; Lymph node metastasis

Indexed keywords

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE CARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 20; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; LYMPHATIC METASTASIS; NUCLEIC ACID HYBRIDIZATION; STOMACH NEOPLASMS;

EID: 0042029327     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kakizoe T ed: Cancer Statistics in Japan 2000. Tokyo, Foundation for Promotion of Cancer Research, 2001.
2. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
3. Sugano H, Nakamura K and Kato Y: Pathological studies of human gastric cancer. Acta Pathol Jpn 32: 329-347, 1982.
4. Tahara E: Molecular biology of gastric cancer. World J Surg 19: 484-490, 1995.
5. Tamura G, Sakata K, Nishizuka S et al: Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180: 371-377, 1996.
6. Wu MS, Shun CT, Wang HP et al: Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 112: 1457-1465, 1997.
7. Kallioniemi OP, Kallioniemi A, Piper J et al: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243, 1994.
8. Kokkola A, Monni O, Puolakkainen P et al: 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 20: 38-43, 1997.
9. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F and Lichter P: Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 23: 307-316, 1998.
10. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE and Mueller W: Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 115: 828-834, 2001.
11. Oga A, Kong G, Ishii Y, Izumi H, Park CY and Sasaki K: Preferential loss of 5q14-21 in intestinal-type gastric cancer with DNA aneuploidy. Cytometry 46: 57-62, 2001.
12. Sakakura C, Mori T, Sakabe T et al: Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24: 299-305, 1999.
13. Fukushige S, Waldman FM, Kimura M et al: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19: 161-169, 1997.
14. Kallioniemi A, Kallioniemi OP, Sudar D et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
15. Kallioniemi A, Kallioniemi OP, Piper J et al: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994.
16. Kallioniemi A, Kallioniemi OP, Citro G et al: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12: 213-219, 1995.
17. Tada K, Oka M, Tangoku A, Hayashi H, Oga A and Sasaki K: Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis. Cancer 88: 268-273, 2000.
18. Korn WM, Yasutake T, Kuo WL et al: Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 25: 82-90, 1999.
19. Nakao K, Shibusawa M, Ishihara A et al: Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91: 721-726, 2001.
20. Nanashima A, Yamaguchi H, Yasutake T et al: Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers. Dig Dis Sci 42: 1388-1393, 1997.
21. Hidaka S, Yasutake T, Takeshita H et al: Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 6: 2712-2717, 2000.
22. Anzick SL, Kononen J, Walker RL et al: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968, 1997.
23. Collins C, Rommens JM, Kowbel D et al: Positional cloning of ZNF217 and NABCI: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95: 8703-8708, 1998.
24. Sen S, Zhou H and White RA: A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14: 2195-2200, 1997.
25. Sakakura C, Hagiwara A, Yasuoka R et al: Amplification and over-expression of the AIB1 nuclear receptor co- activator gene in primary gastric cancers. Int J Cancer 89: 217-223, 2000.
26. Zhou H, Kuang J, Zhong L et al: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193, 1998.
27. Sakakura C, Hagiwara A, Yasuoka R et al: Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 84: 824-831, 2001.
28. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi OP: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21: 177-184, 1998.
29. Candusso ME, Luinetti O, Villani L et al: Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histlogy, but lacks independent prognostic value. J Pathol 197: 44-50, 2002.
30. Fearon ER, Cho KR, Nigro JM et al: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49-56, 1990.
31. Eppert K, Scherer SW, Ozcelik H et al: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
32. Hahn SA, Schutte M, Hoque AT et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271: 350-353, 1996.
33. Yoshida Y, Itoh F, Endo T, Hinoda Y and Imai K: Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int J Cancer 79: 634-639, 1998.
34. Shitara Y, Yokozaki H, Yasui W et al: No mutations of the Smad2 gene in human sporadic gastric carcinomas. Jpn J Clin Oncol 29: 3-7, 1999.
35. Xiangming C, Natsugoe S, Takao S et al: Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res 7: 277-282, 2001.